Zollinger-Ellison Syndrome is a rare disorder that causes tumors and ulcers in the digestive system. One or more tumors form in the pancreas or duodenum (the upper part of the small intestine). These tumors, called gastrinomas, produce a large amount of gastrin. Gastrin is a hormone that causes the stomach to produce acid. With too much gastrin, excess acid is produced, causing ulcers.
Gastrinomas occur as single tumors or small multiple tumors. Not only can these tumors lead to ulcers, they can also be cancerous (up to 90% malignant) and spread to the nearby lymph nodes or liver. This happens in about one-third to one-half of the cases of Zollinger-Ellison Syndrome.
About one-third of people with Zollinger-Ellison Syndrome have a genetic disorder called multiple endocrine neoplasia type 1 (MEN 1). Patients with MEN 1 have additional endocrine tumors in the brain and neck.
Causes
The cause of Zollinger-Ellison Syndrome is unclear. It is very rare; fewer than three out of a million people have the syndrome.
Symptoms
Over 90% of people with Zollinger-Ellison Syndrome have symptoms typical of a stomach ulcer.
If you experience any of these symptoms do not assume it is due to Zollinger-Ellison Syndrome. These symptoms may be caused by other, less serious health conditions:
Diagnosis
Your doctor will ask about your symptoms and medical history, and perform a physical exam. He or she may also refer you to a gastroenterologist, a specialist who deals with gastrointestinal disorders.
Tests may include the following:
Treatment
Talk with your doctor about the best treatment plan for you. Treatment options include:
Surgical Removal of Tumor
If there is only one tumor and it isn’t cancerous, a surgical removal may be attempted.
Medications for Ulcers
Proton pump inhibitors are medications that reduce acid by blocking the ‘pumps’ in acid-secreting cells. Examples include Nexium, Prevacid, Protonix, and Prilosec.
Histamine blockers are medications to reduce the amount of hydrochloric acid released by the stomach. This will relieve pain and allow the ulcers to heal.
Chemotherapy is used in those with malignant form.
Control tumor growth with the use of somatostatin analogs (e.g. octreotide)
RESOURCES:
American Gastroenteroligical Association
http://www.gastro.org
National Digestive Diseases Information Clearinghouse
http://digestive.niddk.nih.gov
CANADIAN RESOURCES:
Canadian Health Network
http://www.canadian-health-network.ca
References:
Berna MJ, Hoffmann KM, Long SH, et al. Serum gastrin in Zollinger-Ellison syndrome: II. Prostpectie study of gastrin provocative testing in 293 patients from the National institutes of Health and comparision with 537 cases fromt eh literature, evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine. 2006;85:331-64.
Notron JA, Jensen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison Syndrome. Ann Surg. 2004;240:757-73.
Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med. 1999;341:635-644.
Pellicano R, De Angelis C, Resegotti A, Rizzetto M. Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view. Panminerva Med. 2006;48:33-40.
Zollinger-Ellison syndrome. Mayo Clinic website. Available at: http://www.mayoclinic.com/invoke.cfm?id=DS00461. Accessed September 12, 2005.
Zollinger-Ellison syndrome. US National Library of Medicine website. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/000325.htm. Accessed September 12, 2005.
